(NASDAQ:CYCC),(NASDAQ:CYCCP), Kuala Lumpur, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it has entered into an amendment to the Exchange Agreement with FITTERS Diversified Berhad (9318.KL; “FITTERS”), an investment holding company engaged, through its subsidiaries, in […]

(NASDAQ:CYCC),(NASDAQ:CYCCP), – Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in adolescents and young adults – KUALA LUMPUR, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative cancer medicines, highlighted a publication from independent investigators titled, “DNAJ-PKAc fusion

VICTORIA, Seychelles, July 07, 2025 (GLOBE NEWSWIRE) — MEXC, a leading global cryptocurrency exchange, today announced the successful conclusion of its Golden Era Showdown mid-year trading event. The three-week event attracted over 200,000 participants and unlocked the full 4 million USDT prize pool, setting a new milestone in global trading engagement for the platform. Participants

(NYSE MKT:AMBO), CUPERTINO, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Ambow Education Holding Ltd. (NYSE American: AMBO), a leading global provider of AI-driven education and collaboration technology, today announced the launch of HybriU Knowledge Capture, a strategic expansion of the Company's award-winning HybriU platform–originally developed for education environments–now adapted to help enterprises preserve critical knowledge,

(NasdaqGM:APGE), APEX Part A met all primary and key secondary endpoints and exceeded trial objectives, including 71.0% decrease from baseline in EASI at Week 16 APG777 demonstrated EASI-75 of 66.9% (42.5% placebo-adjusted) at Week 16, the highest topline and placebo-adjusted efficacy of any biologic in a global study Exposure-response relationship observed across multiple key endpoints;

Next-generation UAV purpose-built for wildfire detection, emergency response, and middle-mile logistics to be showcased publicly for the first time at Commercial UAV EXPO 2025 in Las Vegas LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) — AIBOT welcomed the June 6 Executive Order issued by President Donald J. Trump, praising the Administration's proactive steps to accelerate

(TSX-V:NKW-H),(TSX-V:NKW.H), VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) — Oceanic Wind Energy Inc. (“Oceanic”) is proud to announce a major milestone in the advancement of the offshore wind project in Hecate Strait, located just west of Stephens Island. In partnership with Coast Tsimshian Enterprises Ltd. (“CTE”), Oceanic has been jointly granted an Investigative Use

(TSX:BBD-A),(TSX:BBD-B),(OTC US:BDRBF),(Other OTC:BDRBF), Bombardier's Innovation and Design Centre, represents a major milestone, and will deliver innovations that continuously enhance and define our customers' experience Located in Montreal, the space will enable the teams to secretly and rapidly test innovative products ahead of integrating them into the aircraft portfolio The Centre will house full-scale cabin mockups

SAN MATEO, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Vyond, the effortless, all-in-one video creation platform, is now officially FedRAMP-authorized to operate and listed in the FedRAMP(R) marketplace at https://marketplace.fedramp.gov/products/FR2433985791. Thousands of federal agencies and government entities are now able to apply for a reciprocal ATO to use Vyond for Government. Vyond transforms critical information

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER GlobeNewswire July 07, 2025 – Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in adolescents and young adults – KUALA LUMPUR, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC,